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We take for granted the ability to fall asleep or to snap out of sleep into wakefulness, but these changes in
behavioral state require specific switching mechanisms in the brain that allow well-defined state transitions.
In this review, we examine the basic circuitry underlying the regulation of sleep and wakefulness and discuss
a theoretical framework wherein the interactions between reciprocal neuronal circuits enable relatively rapid
and complete state transitions. We also review how homeostatic, circadian, and allostatic drives help regu-
late sleep state switching and discuss how breakdown of the switching mechanism may contribute to sleep
disorders such as narcolepsy.We spend nearly one-third of our lives asleep, and many
mammals, including small laboratory rodents, spend half or
more of their existence in this state (Savage and West, 2007;
Siegel, 2009). Because sleeping animals are inherently more
vulnerable, it is necessary for an animal to be able to awaken
quickly so it can flee or defend itself. Conversely, it is a common
experience that one can fall asleep over just a few seconds or
minutes. These state transitions involve dramatic alterations in
easily observed physiological variables, including eye closure,
breathing, arousability, and muscle tone. We measure the
changes in cortical activity and muscle tone, respectively, by
recording the electroencephalogram (EEG) and electromyogram
(EMG), and the actual transitions in electrophysiologically moni-
tored state occur over just a few seconds (Takahashi et al.,
2010). Similarly, during the sleep period, animals and people
rapidly transition between rapid eye movement (REM) and
non-REM (NREM) sleep states. Recent advances in under-
standing the brain circuitry underlying the waking and sleeping
states have given rise to models that may explain these transi-
tions. The principles that govern these models for state transi-
tions may ultimately apply to many other state changes, such
as emotional responses, sexual arousal, or cognitive state
changes such as reorienting attention. Hence the mechanisms
for wake-sleep state transitions potentially have broad implica-
tions for a variety of behavioral states.
As an individual falls asleep, the EEG initially transitions from
a state of high-frequency, low-voltage waves in the waking state
to higher voltage, slower waves representing NREM sleep.
These changes take place over a few seconds or less in rodents
but may take 10 s to a minute in humans (Takahashi et al., 2010;
Wright. et al., 1995). The EEG then progressively slows during
NREM sleep until it is dominated by high-voltage, slow wave
(0.5–4 Hz) activity, after which the slow waves progressively
diminish, a typical bout lasting from 40 min to an hour or more
in humans. In rodents, this process is much shorter, with slow
waves established within seconds of entering NREM sleep,
and the entire NREM bout generally lasting three to five minutes,
although occasionally it may extend to 20 min or more. Across
species, wake bout lengths follow a power law distribution (the
log of probability of a bout of a certain length and the log of thebout length forming a linear relationship), whereas the durations
of sleep bouts follow an exponential distribution (Lo et al., 2004;
Phillips et al., 2010). In each case though, the transitions
between NREM sleep and wakefulness typically take less than
1% of the duration of an average NREM bout. The EEG then
makes another abrupt transition over a few seconds from
NREM into REM sleep, with lower voltage, higher frequency
activity. In rodents, the EEG recorded from the cortical surface
during REM sleep is dominated by 5–8 Hz theta activity gener-
ated by the underlying hippocampus; in humans, theta activity
is present during REM sleep, particularly in the hippocampus,
but the dominant cortical frequencies are faster and lower
voltage. During REM sleep, there is almost complete loss of
tone in skeletal muscles (except those used for breathing and
eye movements), accompanied by rapid eye movements that
give the state its name. Humans report active dreams during
REM sleep but less lively mentation during NREM sleep. Over
the sleep period, an individual may switch back and forth from
NREM to REM sleep, with occasional transitions to periods of
wakefulness. The duration of the NREM, REM, and wake bouts
varies with the species, age, and health of the individual, but
the electrographic transitions between these states are relatively
rapid in comparison to bout duration.
Researchers first began mapping the general circuitry that
controls wakefulness and sleep over 50 years ago, and in the
last 10–20 years, much has been learned about the specific
systems that regulate these states. Progress over the last few
years has been especially rapid, leading to an improved under-
standing of the neurochemicals, pathways, and firing patterns
that regulate NREM and REM sleep. Other new work has exam-
ined the ways in which behavioral drives, including homeostatic,
circadian, and allostatic influences, may affect these switching
mechanisms. We will first review these advances and place
them into the context of a model we have proposed for sleep/
wake state transitions based upon mutually inhibitory circuits,
as are seen in electronic flip-flop switches (Saper et al., 2001,
2005). We will then explore recently proposed mathematical
models based on this circuitry that can explain many of the
features of natural sleep and state transitions. Finally, we will
examine how this circuitry can explain many of the features ofNeuron 68, December 22, 2010 ª2010 Elsevier Inc. 1023
Figure 1. The Wake-Sleep Switch
Many wake-promoting projections arise from neurons in the upper brainstem
(A). Cholinergic neurons (aqua) provide the major input to the thalamus,
whereasmonoaminergic and (presumably) glutamatergic neurons (dark green)
provide direct innervation of the the hypothalamus, basal forebrain, and cere-
bral cortex. The orexin neurons in the lateral hypothalamus (blue) reinforce
activity in these brainstem arousal pathways and also directly excite the
cerebral cortex and BF. The main sleep-promoting pathways (magenta in B)
from the ventrolateral (VLPO) and median (MnPO) preoptic nuclei inhibit the
components of the ascending arousal pathways in both the hypothalamus
and the brainstem (pathways that are inhibited are shown as open circles
and dashed lines). However, the ascending arousal systems are also capable
of inhibiting the VLPO (C). This mutually inhibitory relationship of the arousal-
and sleep-promoting pathways produces the conditions for a flip-flop switch,
which can generate rapid and complete transitions between waking and
sleeping states. The following abbreviations are used: DR, dorsal raphe
nucleus (serotonin); LC, locus coeruleus (norepinephrine); LDT, laterodorsal
tegmental nucleus (acetylcholine); PB, parabrachial nucleus (glutamate); PC,
precoeruleus area (glutamate); PPT, pedunculopontine tegmental nucleus
(acetylcholine); TMN, tuberomammillary nucleus (histamine); vPAG, ventral
periaqueductal gray (dopamine).
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which the circuitry that stabilizes switching is damaged.
Networks Supporting Sleep and Wakefulness
Wake-Promoting Networks
Current models of the ascending arousal system are still gener-
ally based on the observations by Moruzzi and Magoun (1949)
that electrical stimulation of the paramedian reticular formation,
particularly within the midbrain, produces EEG desynchroniza-
tion consistent with arousal. Subsequent studies identified
a slab of tissue at the junction of the rostral pons and caudal
midbrain as critical for maintaining the waking state (Lindsley
et al., 1949). Although the neurons responsible for arousal
were initially thought to be part of the undifferentiated reticular
formation, subsequent studies showed that the cell groups at
the mesopontine junction that project to the forebrain mainly
consist of monoaminergic and cholinergic neurons that reside
in specific cell groups rather than the reticular core (Figure 1)
(see Saper [1987] for review).
Cholinergic neurons that project to the forebrain are found in
the pedunculopontine and laterodorsal tegmental nuclei (PPT
and LDT). They provide the main innervation from the mesopon-
tine junction to the thalamic relay nuclei but also innervate the
intralaminar and reticular thalamic nuclei, as well as the lateral
hypothalamus, basal forebrain, and prefrontal cortex (Hallanger
et al., 1987; Satoh and Fibiger, 1986). Many neurons in the
PPT and LDT fire most rapidly during wakefulness and REM
sleep, and most slowly during NREM sleep, suggesting that
they help drive cortical activation (el Mansari et al., 1989;
Steriade et al., 1993). These nuclei are heterogeneous, but extra-
cellular recordings combined with juxtacellular labeling confirm
that cholinergic neurons in the LDT fire during cortical activation,
usually increasing their firing rates just before the transition from
cortical slow waves to faster frequencies (Boucetta and Jones,
2009).
The monoaminergic cell groups at the mesopontine level that
project to the forebrain include the noradrenergic locus coeru-
leus (LC) and the serotoninergic dorsal and median raphe nuclei
(Aston-Jones and Bloom, 1981; Dahlstroem and Fuxe, 1964;
Kocsis et al., 2006), as well as dopaminergic neurons adjacent
to the dorsal raphe nucleus (Lu et al., 2006a). Histaminergic
neurons in the tuberomammillary nucleus (TMN) have similar
projection targets and firing patterns (Panula et al., 1989;
Steininger et al., 1999). Axons from these cell groups predomi-
nantly target the lateral hypothalamus, basal forebrain, and
cerebral cortex, where they terminate extensively, particularly
in the prefrontal cortex. Each of these monoaminergic systems
also sends smaller but important populations of axons to the
thalamus where they largely target the intralaminar and reticular
nuclei. Generally, neurons in these cell groups fire most actively
during wakefulness, decrease activity during non-REM sleep,
and fall silent during REM sleep (Aston-Jones and Bloom,
1981; Kocsis et al., 2006; Steininger et al., 1999; Takahashi
et al., 2006, 2010).
Another source of arousal influence from the rostral pons may
be glutamatergic neurons in the parabrachial nucleus and the
adjacent precoeruleus area (PC, the lateral corner of the rostral
pontine periventricular gray matter, just rostral to the main1024 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.
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tions to the lateral hypothalamus, basal forebrain, and cerebral
cortex (Hur and Zaborszky, 2005; Lu et al., 2006b;Saper, 1987;
Saper and Loewy, 1980). The activity patterns of these glutama-
tergic neurons have not yet been studied, but recordings in this
area in cats and Fos studies in rats have shown predominantly
wake- and REM-sleep-active neurons (Chu and Bloom, 1973;
Lu et al., 2006b; Saito et al., 1977). Tests of the role of these
neurons in wakefulness would be of great interest.
Several forebrain neuronal systems also support wakefulness.
The importance of these forebrain regions is underscored by the
observation that over a period of weeks to months after acute
lesions of the brainstem arousal system, animals and humans
eventually recover wake-sleep cycles (Adametz, 1959; Posner
et al., 2008). Thus, while these forebrain areas appear to depend
upon the brainstem arousal influence in the intact individual, they
apparently can reorganize to support cortical arousal even
without input from the brainstem.
One of these forebrain arousal systems is found in the poste-
rior half of the lateral hypothalamus. Just dorsal and rostral to the
histaminergic neurons of the TMN, the lateral hypothalamus
contains neurons producing the orexin neuropeptides (orexin-A
and -B, also known as hypocretin-1 and -2). Many of the orexin
neurons also contain glutamate, and nearly all also contain the
neuropeptide dynorphin (Chou et al., 2001; Torrealba et al.,
2003). They send axons to the entire cerebral cortex, as well
as to the brainstem and basal forebrain, with particularly intense
input to the TMN and the LC (Peyron et al., 1998). There is also
less intense orexin innervation of the intralaminar nuclei of the
thalamus as well as the anteroventral thalamic nucleus. There
are two known orexin receptors, both of which are G protein
coupled receptors with excitatory membrane effects (Sakurai
et al., 1998). Orexin neurons receive afferents frommany compo-
nents of the ascending arousal system, including the LC, dorsal
raphe (DR), and parabrachial nucleus, as well as from cortical
(medial prefrontal) and amygdaloid (central nucleus) sources
associated with arousal and ventral tegmental sites associated
with reward (Yoshida et al., 2006). They fire predominantly during
wakefulness, and fire particularly briskly during active explora-
tion of the environment or during motivated behaviors (Lee
et al., 2005; Mileykovskiy et al., 2005). Orexin neurons are also
driven by low glucose (Moriguchi et al., 1999) and may play an
important role inmotivating foraging behaviors in hungry animals
as well as in reward and drug seeking behaviors (Harris et al.,
2005; Yamanaka et al., 2003). Selective activation of the orexin
neurons with a light-sensitive sodium channel awakens mice
from sleep, suggesting that the orexin neurons are capable of
driving arousal from sleep (Adamantidis et al., 2007; Carter
et al., 2009). Most importantly, selective destruction of the orexin
neurons with a genetically targeted toxin results in the symptoms
of narcolepsy (Hara et al., 2001), which will be discussed in
a separate section below. Overall, the orexin neurons are
thought to sustain wakefulness and suppress REM sleep.
On the other hand, large lesions of the posterior lateral hypo-
thalamus (Gerashchenko et al., 2003; Nauta, 1946; Ranson,
1939; Swett and Hobson, 1968) produce much more extensive
sleepiness than can be explained by elimination of just orexin
and histamine transmission. This suggests the presence of otherimportant arousal-producing neurons in the posterior lateral
hypothalamus. There is an additional population of neurons in
the supramammillary region and extending laterally to the sub-
thalamic nucleus, which is a known source of projections to
the cerebral cortex and basal forebrain (Grove, 1988; Saper,
1985). Many neurons in this region express the vesicular gluta-
mate transporter 2 (Hur and Zaborszky, 2005; Ziegler et al.,
2002) but whether these glutamatergic neurons promote arousal
remains to be determined.
The most rostral population of arousal-promoting subcortical
neurons is located in the basal forebrain. Many of these
neurons contain either acetylcholine or gamma-amino-butyric
acid (GABA), and a small number contain glutamate (Manns
et al., 2001; Hur and Zaborszky, 2005). Basal forebrain cholin-
ergic neurons innervate, both directly and indirectly activate
cortical pyramidal cells, and probably augment cortical activa-
tion and EEG desynchronization (Jones, 2004). GABAergic basal
forebrain neurons innervate and presumably inhibit cortical
GABAergic interneurons and deep layer pyramidal cells (Freund
and Meskenaite, 1992; Henny and Jones, 2008), both of which
most likely result in disinhibition of cortical circuits. Many of
these basal forebrain neurons are wake-active and fire in bursts
correlated with specific EEG rhythms. Small ibotenic acid lesions
of the basal forebrain result inmodest slowing of the EEGwithout
changing the amount of wake or sleep, while specific lesions of
basal forebrain cholinergic neurons reduce wakefulness tran-
siently, without affecting the EEG frequency spectrum (Kaur
et al., 2008). On the other hand, acute inactivation of the basal
forebrain with the anesthetic procaine produces deep NREM
sleep, whereas activation with glutamatergic agonists causes
wakefulness (Cape and Jones, 2000). A definitive understanding
of the roles of the basal forebrain cell groups in arousal awaits
studies that differentially eliminate the GABAergic population.
The thalamic relay nuclei (such as the anterior, ventral, and
lateral thalamic cell groups; medial and lateral geniculate nuclei;
mediodorsal nucleus; and pulvinar) are the most important and
abundant sources of subcortical glutamatergic afferents to the
cerebral cortex, and the intralaminar and midline nuclei provide
a diffuse source of cortical input (Jones and Leavitt, 1974).
Surprisingly, there is little evidence that these inputs play amajor
role in producing wakefulness. Early electrical stimulation
studies suggested that the midline and intralaminar thalamic
nuclei might constitute a diffuse, nonspecific cortical activating
system (Morison and Dempsey, 1942; Steriade, 1995), but
lesions of the midline and intralaminar nuclei did not prevent
cortical activation (Moruzzi and Magoun, 1949; Starzl et al.,
1951). Extensive ablation of the thalamus in cats actually caused
an increase in wakefulness (Villablanca and Salinas-Zeballos,
1972) but in rats has been reported to have little if any effect
on wakefulness or EEG waveforms, other than to eliminate sleep
spindles (Buzsaki et al., 1988; Vanderwolf and Stewart, 1988).
When overall arousal is impaired with thalamic lesions in
humans, close examination of the pathology has shown that
there is also damage to the paramedian midbrain or underlying
hypothalamus (Posner et al., 2008). Conversely, patients with
bilateral thalamic damage are often in a persistent vegetative
state, with preserved wake-sleep cycles but without retained
cognitive content (Kinney and Samuels, 1994), and patientsNeuron 68, December 22, 2010 ª2010 Elsevier Inc. 1025
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loss (Montagna et al., 2003). It is difficult to reconcile these
observations with the thalamus playing a role in promoting over-
all cortical arousal.
On the other hand, the thalamus may be important for
selecting aspects of the environment for attention and in this
regard may interact with the arousal system. Selective activation
of specific cortical areas is thought to be regulated by the
reticular nucleus of the thalamus, which covers the rostral and
lateral surface of the thalamus and has a major inhibitory influ-
ence over the thalamic relay nuclei. The reticular nucleus
consists of GABAergic neurons, which sample thalamocortical
traffic, and inhibit thalamic relay neurons, resulting in targeted
modulation of thalamocortical transmission. Thus, selective
inhibition of thalamic reticular neurons may be a critical mecha-
nism for selective attention and a major function of the arousal
system. Inputs to the reticular nucleus arise from cholinergic
(Levey et al., 1987; Parent and Descarries, 2008), noradrenergic
(Asanuma, 1992), serotoninergic, and histaminergic (Manning
et al., 1996) arousal systems, along with pyramidal neurons
of the frontal cortex (Zikopoulos and Barbas, 2007), and
GABAergic neurons of the basal forebrain (Asanuma, 1989; Asa-
numa and Porter, 1990; Bickford et al., 1994). These probably
represent important mechanisms through which the brainstem,
basal forebrain, and frontal cortex modulate activity within thala-
mocortical circuits.
Finally, the telencephalon is not just a target of the arousal
system (as measured by EEG and behavioral activation), but
itself contributes to regulation of arousal. All components of
the arousal system intensively innervate the prefrontal cortex,
in particular the medial prefrontal region, which in turn sends
descending projections back to the basal forebrain, hypothal-
amus, and brainstem components of the arousal system (Aston-
Jones and Cohen, 2005; Hurley et al., 1991). Reciprocal excita-
tion might allow the medial prefrontal cortex to rapidly escalate
arousal when a behaviorally important stimulus is present.
The presence of such a large number of cell groups that are
thought to promote arousal raises the question of how they
interact in this process. It is interesting that drugs that block
transmission for one or another of these pathways (e.g., musca-
rinic antagonists, H1-histamine antagonists, or a2-adrenergic
agonists) cause acute sleepiness, but chronic ablation of the
basal forebrain cholinergic neurons (Kaur et al., 2008), tubero-
mammillary histaminergic neurons (Gerashchenko et al., 2004),
the LC and pontine cholinergic neurons (Lu et al., 2006a; Shouse
and Siegel, 1992; Webster and Jones, 1988), or combinations of
these structures (Blanco-Centurion et al., 2007) have minimal
effects on the amount of wakefulness. One possible reason for
this puzzling result is that the arousal system may contain suffi-
cient redundancy that remaining wake-promoting systems may
be able to compensate for the chronic (but perhaps not acute)
loss of one or even a few components, e.g., by increasing activity
or receptor sensitivity in intact arousal systems.
A related issue is which of these wake-promoting cell groups
participate in the switching between sleep and wakefulness,
as opposed to the maintenance of the waking state. This issue
will be taken up in the section of this review on switching
circuitry.1026 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.NREM Sleep-Promoting Networks
During the epidemic of encephalitis lethargica around the time
of the World War I, Von Economo (1930) reported that patients
with lesions in the preoptic region around the rostral end of the
third ventricle demonstrated profound insomnia. Experimental
lesions of the preoptic-basal forebrain region reduced sleep in
rats and cats (McGinty and Sterman, 1968; Nauta, 1946), but
the exact population of sleep-promoting neurons was unknown.
Sherin and colleagues (Sherin et al., 1996) subsequently identi-
fied a population of neurons in the ventrolateral preoptic nucleus
(VLPO) that innervate the histaminergic TMN and that express
Fos protein selectively during sleep but not wakefulness. VLPO
neurons, containing the inhibitory neurotransmitters GABA and
galanin, innervate other components of the ascending arousal
system as well, including the LC, raphe system, periaqueductal
gray matter, parabrachial nucleus, and lateral hypothalamic
area (Sherin et al., 1998). The VLPO was found to consist of
a dense core of sleep-active, galanin-positive neurons that
project heavily to the TMN. However, this is surrounded dorsally
and medially by a more diffuse population of sleep-active, gala-
nin-positive neurons, the extended VLPO, which more exten-
sively targets the dorsal raphe and LC (Lu et al., 2000; Sherin
et al., 1998). As is true for many cell groups in the hypothalamus
that are defined on the basis of common neurotransmitter,
connections and physiology, the VLPO neurons are mixed in
among other cell types. In addition, while there are other galani-
nergic neurons laterally in the basal forebrain and medially in the
preoptic area, none of these are sleep-active or project to the
TMN, LC, or dorsal raphe (Sherin et al., 1998; Gaus et al.,
2002). These complexities make it difficult to interpret single
unit recording studies, which necessarily record from only one
cell at a time, but rarely identify their chemical phenotype. Never-
theless, such recordings in rats demonstrated that many
neurons in the VLPO region fire at about 1–2 Hz during wakeful-
ness, about 2–4 times faster during NREM sleep, and about
twice as fast again during deep NREM sleep after 12 hr of sleep
deprivation (Szymusiak et al., 1998). However, some of the
neurons were found to fire fastest during REM sleep. Similar
observations have been made in mice (Takahashi et al., 2009).
These observations suggest that VLPO neurons constitute
a sleep-promoting pathway from the preoptic area that inhibits
many arousal systems during sleep. However, there are also
somewake-active neuronsmixed in with the VLPO cells (Szymu-
siak et al., 1998; Modirrousta et al., 2004; Takahashi et al., 2009)
whose function with respect to wake-sleep regulation is not
known. To test the net effect of the neurons in the VLPO region
on sleep regulation, Lu et al. (2000) performed sleep recordings
in animals with cell-specific lesions of the VLPO, and these
showed a decrease in NREM, REM, and total sleep by up to
50%. Cell loss in the VLPO core correlated most closely with
loss of NREM sleep, while loss of REM sleep was more closely
correlated with loss of neurons in the extended VLPO (Lu et al.,
2000).
The preoptic area and basal forebrain near the VLPO also
contain other populations of sleep-active neurons (Lee et al.,
2004; Szymusiak and McGinty, 1986; Modirrousta et al., 2004;
Hassani et al., 2009; Takahashi et al., 2009), however the ability
of these cell groups to cause sleep, as opposed to simply firing
Neuron
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tion of neurons in the median preoptic nucleus (MnPO). Like the
VLPO, the MnPO contains many neurons that produce Fos
during sleep and contain GABA (although they do not contain
galanin) (Gong et al., 2004). About 75% of MnPO neurons fire
faster during sleep (Suntsova et al., 2002), although only about
10% are differentially more active in NREM or REM. Unlike
VLPO neurons, whose firing increases at just about the same
time as sleep onset (Szymusiak et al., 1998; Takahashi et al.,
2009), MnPO neurons often fire in advance of sleep, suggesting
a role in accumulating sleep pressure. This hypothesis has been
strengthened by the observation that MnPO neurons also
express Fos during sleep deprivation, while the VLPO neurons
only express Fos during sleep (Gvilia et al., 2006). The MnPO
provides a major input to the VLPO (Chou et al., 2002; Uschakov
et al., 2007), which may allow it to drive VLPO activity. Other
projections from the MnPO target the lateral hypothalamic
area, the dorsal raphe, the LC, and the midbrain periaqueductal
gray matter but not the cholinergic PPT and LDT nuclei or the
TMN (Uschakov et al., 2007). It is not knownwhether the neurons
that contribute to these projections are the same ones that are
sleep-active, GABAergic neurons. Studies of the effects of
selective MnPO lesions on sleep would be of great value in
defining its contribution to sleep regulation.
A key property of VLPO neurons is that they receive reciprocal
inputs from many regions implicated in arousal, including the
TMN, dorsal raphe nucleus and adjacent ventral periaqueductal
gray matter (vlPAG), parabrachial nucleus, and LC (Chou et al.,
2002; Lu et al., 2006a). Slice recordings of identified VLPO
neurons show that they are inhibited by acetylcholine, norepi-
nephrine, dopamine, and serotonin (Gallopin et al., 2000;
Gallopin et al., 2004). While VLPO cells are not inhibited by hista-
mine, the TMN neurons also contain the mu-opioid peptide
endomorphin, which inhibits VLPO neurons (Greco et al.,
2008). MnPO neurons receive only sparse inputs from the LC
and periaqueductal gray matter and little if any from the dorsal
or median raphe nuclei or from the TMN (Saper and Levisohn,
1983). The effects of these inputs on the MnPO sleep-active
neurons remain unknown.
Because even rats with very large VLPO lesions still sleep
about 50% as much as normal animals, it is likely that the
sleep-promoting system in the brain is distributed with compo-
nents in addition to the VLPO thatmay contribute to the inhibition
of the arousal systems during sleep. These may include other
sleep-active neurons in the MnPO and basal forebrain (Modir-
rousta et al., 2004; Takahashi et al., 2009), but evidence that
these cells promote sleep is lacking. Recent studies on lesions
of the striatum and globus pallidus have reported substantial
increases in wakefulness and sleep fragmentation (Qiu et al.,
2010). The descending projections from both the nucleus
accumbens and globus pallidus are largely GABAergic and
include the basal forebrain and lateral hypothalamus (Baldo
et al., 2004; Kim et al., 1976; Swanson and Cwan, 1975). In addi-
tion, a population of cortical neurons has been described that
express cFos during sleep and are immunoreactive for both nitric
oxide and neuropeptide Y (Gerashchenko et al., 2008). However,
their role in producing sleep states, or in state switching, remains
to be studied.Thus, although it is likely that other sleep-promoting neurons
participate in the induction and maintenance of sleep, the
VLPO neurons appear to play a particularly important role in
this process, as VLPO lesions can substantially reduce sleep
formonths (Lu et al., 2000). Therefore, in ourmodel for behavioral
state switching, we will focus on the interactions of the VLPO
with wake-promoting systems.
REM Sleep-Promoting Networks
After the discovery of REM sleep in the 1950s, its regulation
became a major focus of research. Much work has indicated
that neurons in the pons play an essential role as REM sleep is
disrupted by transections of the pons or large excitotoxic lesions
of this region (Jouvet, 1962; Webster and Jones, 1988). In addi-
tion, just prior to and during REM sleep, high-voltage EEGwaves
occur in the pons, lateral geniculate, and occipital cortex (hence
PGOwaves) in cats. These PGOwaves are time locked to bursts
of firing by PGO burst neurons in the region of the cholinergic
PPT and LDT nuclei at the junction of the midbrain and the
pons (el Mansari et al., 1989; Sakai and Jouvet, 1980).
Conversely, firing of neurons in the LC, dorsal raphe nucleus,
and TMN was found to slow almost to a halt during REM sleep
(Aston-Jones and Bloom, 1981; Hobson et al., 1975; Steininger
et al., 1999; Takahashi et al., 2010; Trulson et al., 1981). This
reciprocal relationship suggested that the PPT and LDT might
interact with monoaminergic neurons to regulate the alternation
of NREM and REM sleep.
McCarley andHobson produced a predator-preymodel of this
NREM-REM sleep mechanism using Lottka-Volterra equations
(Hobson et al., 1975; McCarley and Hobson, 1975; Pace-Schott
and Hobson, 2002). In a predator-prey model, an increase in the
prey population allows an increase in the predator population,
but this then reduces the prey population, resulting in a subse-
quent decrease in the predators, thus permitting another cycle
in which the prey population expands again. In the Hobson-
McCarley model, the cholinergic neurons act like prey in that
an increase in their firing during REM sleep excites monoamine
cells. However, the monoaminergic neurons are like predators
in that an increase in their firing inhibits the cholinergic neurons
and terminates the REM period. The oscillations in a predator-
prey model require a substantial time delay between the expan-
sion of the prey and predator populations. While this delay is
maintained by breeding cycles in the predator-prey model, it is
not clear how this model would apply to neurons, which commu-
nicate with each other in a matter of milliseconds.
The model of cholinergic-monoaminergic interactions regu-
lating REM sleep was supported by the observations that appli-
cation of cholinergic drugs to the mesopontine tegmentum can
cause REM sleep, whereas drugs that increase monoaminergic
signaling inhibit REM sleep (Luppi et al., 2006). On the other
hand, the importance of the PPT/LDT and LC in the control of
REM sleep has been challenged by studies in which lesions of
these nuclei had surprisingly little effect on REM sleep. Electro-
lytic lesions of the PPT in cats mildly reduced the number of tran-
sitions into REM sleep, but lesions of the LDT and LC had no
effect (Shouse and Siegel, 1992; Webster and Jones, 1988).
More limited lesions of the PPT or LDT in rats have demonstrated
minimal effects on REM sleep (Lu et al., 2006b). Even quite
complete lesions of the LC using specific toxins showed noNeuron 68, December 22, 2010 ª2010 Elsevier Inc. 1027
Figure 2. The REM-NREM Sleep Switch
Two populations of mutually inhibitory neurons in the upper pons form a switch
for controlling transitions between REM and NREM sleep (A). GABAergic
neurons in the vlPAG and the adjacent LPT (vlPAG/LPT; shown in gold) fire
during non-REM states to inhibit entry into REM sleep. During REM sleep,
they are inhibited by a population of GABAergic neurons in the sublaterodorsal
region (SLD, red) that fire during REM sleep. This mutually inhibitory relation-
ship produces a REM-NREM flip-flop switch, promoting rapid and complete
transitions between these states. The core REM switch is in turn modulated
by other neurotransmitter systems (B). Noradrenergic neurons in the LC and
serotoninergic neurons in the DR (green) inhibit REM sleep by actions on
both sides of the flip-flop switch (exciting REM-off and inhibiting REM-on
neurons) and during REM sleep they are silent (dashed lines), whereas cholin-
ergic neurons (aqua) promote REM sleep by having opposite actions on the
same two neuronal populations. The orexin neurons inhibit entry into REM
sleep by exciting neurons in the REM-off population (and by presynaptic
effects that excite monoaminergic terminals), whereas the VLPO neurons
promote the entry into REM sleep by inhibiting this same target. During REM
sleep (C), a separate population of glutamatergic neurons in the SLD (red) acti-
vates a series of inhibitory interneurons in the medulla and spinal cord, which
inhibit motor neurons, thus producing the atonia of REM sleep. Withdrawal of
1028 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.
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et al., 2006b). Thus, the available evidence suggests that the
cholinergic and monoaminergic systems are potent modulators
of REM sleep but are not likely to participate in its switching
mechanism.
What then are the cell groups in the pons that regulate REM
sleep? To identify populations of REM-promoting neurons,
subsequent studies have examined Fos expression during
periods of augmented REM sleep (Boissard et al., 2002; Lu
et al., 2006b). While these studies have found relatively few
Fos immunoreactive neurons in the PPT or LDT, Fos expression
was elevated in three slightly more caudal cell groups: the sub-
laterodorsal nucleus (SLD), which is ventral and caudal to the
LDT; the precoeruleus region (PC), which lies just dorsal to the
SLD and caudal to the LDT; and the medial parabrachial nucleus
(MPB), which is just dorsolateral to the SLD (Figure 2).
The role of the SLD in producing REM sleep has been studied
by injecting it with bicuculline, a GABA antagonist, which disin-
hibits the SLD neurons and elicits REM sleep-like behavior
(Boissard et al., 2002). Lesions in the SLD region of cats, also
called the subcoeruleus area, have been known since the
1970s to disrupt atonia during REM sleep such that animals
appear to act out their dreams (Hendricks et al., 1982; Sastre
and Jouvet, 1979; Shouse and Siegel, 1992). However, lesions
of the SLD in rats have more profound effects, fragmenting
and reducing the amount of REM sleep (Lu et al., 2006b).
Injections of retrograde tracers into the SLD identified major
GABAergic inputs from the vlPAG and adjacent lateral pontine
tegmentum (LPT) (Boissard et al., 2003; Lu et al., 2006b). This
same region receives convergence of inputs from the extended
VLPO and the orexin neurons in the lateral hypothalamus
(Lu et al., 2006b). Because the extended VLPO neurons
promote REM sleep but are inhibitory, and the orexin neurons
prevent REM sleep and are excitatory, the vlPAG-LPT region
would be expected to prevent REM sleep. As neurons in the
vlPAG-LPT that project to the SLD are GABAergic, they would
be expected to fire when REM sleep is inhibited (i.e., to show
a REM-off firing pattern). Indeed, inhibition of the vlPAG and
LPT with GABA agonists increases REM sleep (Crochet et al.,
2006; Sapin et al., 2009; Sastre et al., 1996), and lesions in-
crease REM sleep, particularly during the dark phase (Lu et al.,
2006b).
Injections of retrograde tracers into the vlPAG and LPT
demonstrate retrogradely labeled GABAergic neurons in the
SLD and anterogradely labeled axons from the SLD are found
in close apposition to GABAergic neurons in the vlPAG and
LPT (Lu et al., 2006b). These findings suggest that the vlPAG-
LPT and the SLD have a mutually inhibitory relationship that
may govern switching in and out of REM sleep, much like the
relationship between the VLPO and the ascending arousal
systems, which we hypothesize is the basis for switching
between sleep and wake states.tonic excitatory input from the REM-off regions may also contribute to the loss
of muscle tone. At the same time, ascending projections from glutamatergic
neurons in the PB and PC activate forebrain pathways that drive EEG desynch-
ronization and hippocampal theta rhythms, thus producing the characteristic
EEG signs of REM sleep.
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GABAergic neurons give rise to long projections that activate
the principle components of the REM state (Lu et al., 2006b;
Luppi et al., 2004; Luppi et al., 2006; Shouse and Siegel, 1992;
Webster and Jones, 1988). Many of these neurons in the SLD
contain Fos protein during REM sleep, and they send descend-
ing projections to brainstem and spinal inhibitory systems that
ultimately hyperpolarize motor neurons and cause atonia (Lu
et al., 2006b; Luppi et al., 2004; Vetrivelan et al., 2009). In addi-
tion, mixed in with the REM-off GABAergic neurons is a REM-off
glutamatergic population with spinal projections that may
support motor tone during NREM sleep. Inhibition of these
neurons during REM may withdraw motor tone, contributing to
atonia in at least some motor neuron pools (Burgess et al.,
2008). Other glutamatergic REM-on neurons in the parabrachial
nucleus and PC project to the forebrain and cause the EEG
phenomena that characterize REM sleep (Lu et al., 2006b).
Because these REM effector neurons are in isolated pools,
they can be regulated independently. In a healthy brain this rarely
occurs, but in the absence of sufficient input from the orexin
system, the components of the REM switch can become
unstable and independent (see section on narcolepsy below).
As with the regulation of wakefulness, the lateral and posterior
hypothalamus contains a large number of neurons that influence
REM sleep. Neurons producing the peptide melanin-concen-
trating hormone (MCH) are mixed in with the orexin neurons
and innervate many of the same targets. Interestingly, the
MCH neurons fire mainly during REM sleep (Hassani et al.,
2009; Verret et al., 2003). MCH inhibits target neurons, and
many of the MCH neurons contain the inhibitory amino acid
transmitter GABA (Elias et al., 2001). This gives them the exact
opposite activity profile and neurotransmitter action as the
orexin neurons, inhibiting the same targets during sleep that
the orexin neurons activate during wakefulness. Intraventricular
injection of MCH increases REM sleep (Verret et al., 2003), and
an MCH antagonist decreases REM sleep (Ahnaou, 08). Still, it
remains unclear whether the MCH neurons are truly necessary
for REM sleep as mice lacking MCH or the MCH1 receptor
have no clear decrease in the daily amount of REM sleep
(Adamantidis et al., 2008; Willie et al., 2008).
A Flip-Flop Model of Sleep State Transitions
The Flip-Flop Switch Model
As outlined above, one of the most remarkable features of
these state control systems is that both the wake- and sleep-
promoting neurons, like the REM-on and REM-off neurons in
the pons, appear to be mutually inhibitory. We propose that
this mutually antagonistic relationship can give rise to behavior
similar to that seen with a flip-flop switch (Saper et al., 2001;
Mano and Kime, 2004). These types of switches are incorpo-
rated into electrical circuits to ensure rapid and complete state
transitions. In the brain, because the neurons on each side of
the circuit inhibit those on the other side, if either side obtains
a small advantage over the other, it turns the neurons off on
the other side, thus causing a rapid collapse in activity and
a switch in state. Although an electronic flip-flop switch contains
a single element on either side and acts almost instantly, in the
brain the mutual antagonism is between large populations ofneurons, numbering in the thousands on each side, which may
also be responding to other inputs. As a result, the transitions
occur over seconds to minutes (depending upon the species
being studied), but result in clearcut changes in behavioral
and EEG states. Recordings in a wide range of species show
that the transitions typically take less than 1% of bout length
(Takahashi et al., 2010; Wright et al., 1995). Once a state
boundary is crossed, the firing of the counterpoised population
is suppressed. In practical terms, this should produce stable
wake and sleep, preventing an individual from falling asleep
during a boring activity or waking up during the night with every
small sound in the house.
Although the concept of mutual inhibition causing relatively
rapid and complete state transitions is analogous to an elec-
tronic flip-flop switch in some ways, the changes in behavioral
state are not instantaneous and generally take place over
a few seconds in rodents or a few minutes in humans. Individual
neurons in the VLPO, LC, and TMN of rodents change their firing
rates over less than a second when transitioning from wake to
NREM or from NREM to wake (Takahashi et al., 2006, 2009,
2010) (Figure 3), but not all of the neurons in a population will
switch at the same instant. Thousands of sleep- and wake-
promoting cells must shift their activity, and the emergent behav-
ioral state most likely reflects the summated activity across all
these neurons. The time it takes for one population of neurons
to overcome the resistance of the other population and the
stability of the state once that transition point is crossed may
vary with the size and complexity of the brain. This may explain
why bout durations and transition state durations vary in a similar
proportion across a wide range of mammals (Lo et al., 2004;
Phillips et al., 2010) On the other hand, the rate of change in firing
of the two populations is maximal near the inflection point (the
half-way point in the transition) so that the behavioral state
changes often appear to occur rather rapidly.
The REM-off and REM-on neuronal populations in the meso-
pontine tegmentum are also configured in a mutually inhibitory
circuit (Lu et al., 2006b; Luppi et al., 2004, 2006; Sapin et al.,
2009; Sastre et al., 1996; Verret et al., 2006). Each population
is a mixture of both GABAergic neurons and glutamatergic
neurons. The GABAergic neurons in each cluster innervate and
inhibit both the GABAergic and glutamatergic neurons in the
other side of the switch. The result is that transitions into and
out of REM sleep are rapid and complete. As would be predicted
from this arrangement, lesions of either the REM-on or REM-off
population respectively reduce or increase the time spent in
REM sleep, but both NREMandREMsleep become fragmented.
Mathematical Modeling of the Flip-Flop Switch
Hypothesis
Mathematical modeling of these mutually inhibitory circuits can
generate simulated sleep-wake behavior with temporal proper-
ties very similar to those seen in natural sleep-wake transitions.
Phillips and Robinson (2007) used a model based upon the
mutual inhibitory interactions of the VLPO and the monoamin-
ergic systems and included both homeostatic and circadian
influences (see next section). By varying the time constant for
the buildup of homeostatic sleep drive and the mean drive to
the VLPO, they could produce sleep patterns that mimicked
those seen in a wide range of mammals, from rodents to humansNeuron 68, December 22, 2010 ª2010 Elsevier Inc. 1029
Figure 3. Reciprocol Firing Patterns between Sleep-Promoting
Neurons in the Preoptic Area and Wake-Promoting Neurons in the
LC, TMN, and Basal Forebrain
Top: Changes in firing rate during the transition from NREM sleep to wake and
(bottom) firing rates during the transition from wake into light NREM sleep.
Note that the firing rates of some cell groups, such as the LC, begin to increase
or decrease 1–2 s in advance of awakening or falling asleep, suggesting that
they may help drive the transition. In contrast, neurons in the TMN begin to
fire only after the transition to wake, suggesting these cells may play more of
a role in maintenance of wakefulness. Recordings were made in unanesthe-
tized, head-restrained mice. Adapted with permission from Takahashi et al.
(2010).
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sleep deprivation and produced estimates of sleep debt and
recovery in good agreement with experimental data (Phillips
and Robinson, 2008). They then added an arousing stimulus to
their model in the form of a simulated auditory tone that provided
a sensory input to activate the monoaminergic systems (Fulcher
et al., 2008). Their modeling of arousal threshold and its variation
across the night closely approximates responses seen in clinical
studies.
Rempe and colleagues (Rempe et al., 2010) used coupled
oscillator equations to implement a similar model that also incor-
porated both the wake-sleep and REM-NREM circuitry and
integrated them with models of circadian and homeostatic influ-
ences. Their model produced simulated behavior that agreed
well with experimental data in intact individuals and demon-1030 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.strated increased sleep and wake fragmentation in individuals
with loss of orexin neurons as is seen in narcolepsy (see final
section). Diniz Behn and colleagues (Diniz Behn et al., 2008)
also used coupled oscillator equations to incorporate the influ-
ence of the orexin neurons into the flip-flop switch model,
showing how these neurons stabilize behavioral state by pro-
longing the duration of both waking and sleeping bouts. They
have also been able to use this model to reproduce accurately
the effects of pharmacological agents on sleep and wakefulness
(Diniz Behn and Booth, 2010).
Flip-flop models for neuronal circuitry have recently been
proposed to explain rapid and complete state transitions in func-
tions as diverse as alternating zigzag turns in silkworm moths,
visual perceptual rivalry in the brains of primates, and Parkinso-
nian tremor in humans (Burne, 1987; Iwano et al., 2010; Lank-
heet, 2006). In fact, mutually inhibitory relationships may be
a common motif in a wide variety of neural circuits that require
rapid and complete state transitions. This property is critical
for wake-sleep circuitry because, as we will discuss below,
homeostatic and circadian drives for sleep and wake accumu-
late slowly over many hours. In the absence of a switchingmech-
anism, an individual would drift slowly back and forth between
sleep and wakefulness over the course of the day, spending
much of the time somewhere in between in a twilight state.
Clearly, a half-asleep state would be a liability in finding food
or avoiding predation. When conditions of external threat
demand sudden state changes (an allostatic input, see next
section), the flip-flop mechanism ensures that the transition is
accomplished rapidly.
Experimental Evidence for the Flip-Flop Model
Experimental evidence bearing on the flip-flop model derives
from three lines of work. First, direct recordings from neurons
in the cell groups that constitute the model show that their
behavior is very close to what the model would predict. Record-
ings from VLPO neurons in both rats and mice show a sharp
increase in firing just before or at the transition from waking
to NREM sleep and a sharp decrease in firing just before the
transition from NREM or REM to waking (Szymusiak et al.,
1998; Takahashi et al., 2009). Individual VLPO neurons differ
somewhat in their onset of firing relative to the onset of NREM
sleep, presumably because the individual cells differ slightly in
their inputs and responses. A neural network model of these
neurons permitted the 2000 neurons on each side of the switch
to have independent behavior, and this arrangement demon-
strated a similar variability in the onset of firing compared to
the actual state transition (Chou, 2003). A key feature in both
the modeled neuronal behavior and the actual recordings was
the bistable nature of the firing, with abrupt transitions between
rapid and slow firing right around the actual state transitions.
Another interesting aspect of this system is the time relationship
between changes in VLPO neuron firing and cortical activity. The
onset of firing began about 200 msec before the EEG synchroni-
zation and did not reach a peak until 300 msec after the transi-
tion, whereas the fall in firing occurred over about 200 msec
beginning just before the loss of EEG synchronization (Takahashi
et al., 2009). The neural networkmodel (Chou, 2003) predicts this
behavior, and suggests that it underlies the hysteresis in the
response of the brain to homeostatic sleep drive, as suggested
Figure 4. Space State Analysis of the EEG Enables Visualization of
Distinct Sleep/Wake States and Switching between States
By segmenting the EEG power spectrum into ranges and comparing ratios of
EEG power in different ranges, it is possible to produce graphs that separate
the different wake-sleep states spatially. Higher values on the x axis represent
greater amounts of theta activity (6.5 to 9 Hz), which is characteristic of active
wake and REM sleep. Higher values on the y axis reflect greater amounts of
slow EEG activity as is characteristic of NREM sleep. In these graphs, the
ratios of power in different EEG bands are computed for each second of
EEG activity, which is plotted as a separate point. The EEG and EMG are
then scored by experimenters, who designate each second as wake (blue),
NREM sleep (red), REM sleep (green), or cataplexy (magenta). In a wild-type
mouse (A), the clusters of EEG activity associated with each state are distinct,
but in a narcoleptic mouse lacking orexin peptides (B), the wake and NREM
sleep clusters are closer together with more periods spent in the region
between these states. (C) The average densities of EEG activity as a function
of low-frequency EEG power (a projection of the cluster plots above into the
y axis) in groups of wild-type mice (n = 6) and orexin knockout mice (n = 7).
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homeostatic drive triggers sleep is higher than the threshold at
which falling homeostatic sleep drive terminates sleep. This
property may arise from a key aspect of the mutually inhibitory
sleep-wake circuitry: sleep-promoting VLPO neurons can only
be activated during wakefulness by stimuli that overcome their
inhibition by wake-promoting neurons, but during sleep, when
VLPO neurons are not inhibited by wake-promoting neurons,
they can be activated by relatively weak stimuli such as low
levels of homeostatic sleep drive.
The activity of LC and TMN neurons also anticipates state
transitions (Figure 3). The firing of LC neurons slows many
seconds before sleep onset and then gradually increases 1–2 s
prior to wake onset (Aston-Jones and Bloom, 1981; Takahashi
et al., 2010). The firing of TMN neurons also slows about 1 s prior
to EEG signs of NREM sleep, but, unlike the LC, TMN neurons
only start to fire about 1 s after wakefulness is established (Taka-
hashi et al., 2006). These observations suggest that the inputs to
these different populations of wake- and sleep-promoting
neurons are distinct and that each may contribute differentially
at distinct time points during state transitions. Similar recordings
from the MnPO sleep-related neurons would be of great interest
in this context as the Fos studies suggest that theymight fire with
buildup of homeostatic sleep drive, a property that VLPO
neurons lack (Gong et al., 2004).
Second, lesions of sleep- and wake-regulating cell groups
produce alterations in wake and sleep that are generally consis-
tent with the flip-flopmodel. Lesions of the VLPO not only reduce
the amount of time spent asleep but also reduce the stability in
both sleep and wake, resulting in more frequent transitions
(Lu et al., 2000). Similarly, lesions of REM-off population in the
vlPAG also produce not only increased REM sleep but also frag-
mentation of sleep (Kaur et al., 2009; Lu et al., 2006b), and
lesions of the REM-on neurons in the SLD cause decreased
and fragmented REM sleep as the flip-flop model predicts.
Interestingly, lesions of monoaminergic or cholinergic cell
groups on the arousal side of the switch, either alone or in combi-
nation, have been far less effective either at causing a change
in overall amounts of sleep or in sleep-wake fragmentation
(Blanco-Centurion et al., 2007; Lu et al., 2006b). On the other
hand, the effects on wake and sleep were measured after
recovery from the lesions, which may have permitted surviving
neuronal systems to compensate for the loss of the injured
components (e.g., upregulation of receptors for other wake-
promoting neurotransmitters). However, the prominent loss of
sleep and increase in sleep fragmentation, which lasts for
months after VLPO lesions (Lu et al., 2000), suggests that the
VLPO neurons represent a central and irreplaceable component
of the sleep-promoting system.
Finally, state space analysis of the EEG power spectrum has
recently been used to map the dynamic changes in behavioral
states over time (Figure 4) (Diniz Behn et al., 2010). This method
uses principal components analysis of the EEG to generateWild-type mice (blue line) spend most of their time (high densities) in well-
defined wake and NREM sleep, but orexin knockout mice (green line) spend
more time in the transitional region between wake and NREM sleep, in part
because of the greater number of state transitions in these mice.
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and NREM sleep are reflected as three clusters of points. This
analysis allows the examination of second-by-second variations
in sleep and wakefulness as shown by a moving point traveling
from one state cluster to another as the animal’s EEG character-
istics shift. This approach shows that within states such as wake
or NREM sleep, the EEG changes fairly slowly over time, but
during transitions between states, the EEG rapidly switches
into a new pattern. This property underscores the relatively rapid
changes in neural activity that occur at the boundaries between
states as predicted by the flip-flop model.
The Hands on the Switch: Homeostatic, Circadian,
and Allostatic Influences on Sleep and Wakefulness
Changes in internal physiology and the external environment
influence transitions from one behavioral state to another. Over
time, these forces may change slowly, but, as noted previously,
the shifts in behavioral state are relatively rapid and complete. It
is the job of the switching mechanisms we have described to
respond to these slowly accumulating influences, integrate
them over time, and convert their influence into sharp transitions
in behavioral state. The neurons that regulate switching between
behavioral states receive inputs from a wide range of different
sources (e.g., Chou et al., 2002; Yoshida et al., 2006), and the
circuitry that mediates specific types of influences on state tran-
sitions will be reviewed briefly.
One of the most widely recognized properties of NREM and
REM sleep is that they are homeostatically regulated (Acher-
mann and Borbe´ly, 2003; Borbe´ly and Tobler, 1985). In other
words, if an individual is deprived of sleep for some period of
time, there will be a subsequent increase in the amount of sleep
to compensate. However, the neurochemical factors and
neuronal mechanisms that drive these homeostatic responses
are the subject of ongoing and intense investigation.
Over one hundred years ago, Pieron and Ishimori indepen-
dently discovered that the cerebrospinal fluid of sleep-deprived
dogs contains a sleep-promoting factor (Ishimori, 1909; Legen-
dre and Pieron, 1913). Much recent work has focused on aden-
osine, which may accumulate extracellularly as a rundown
product of cellular metabolism, at least in some parts of the
brain (Benington and Heller, 1995; Huang et al., 2005; Porkka-
Heiskanen et al., 1997; Radulovacki et al., 1984; Strecker
et al., 2000). Astrocytes are the main site of energy storage in
the brain in the form of glycogen granules that are depleted
during prolonged waking (Kong et al., 2002). As these energy
stores run down, astrocytes may cause an increase in extracel-
lular adenosine that then promotes sleep. This phenomenon
was nicely demonstrated in a recent study in which genetic
deletion that blocked the rise in adenosine mediated by astro-
cytes prevented rebound recovery sleep after sleep deprivation
(Halassa et al., 2009).
There are two major classes of adenosine receptors in the
brain. Adenosine A1 receptors are predominantly inhibitory,
while A2a receptors are excitatory. Signaling through A1 recep-
tors, which are diffusely distributed in the brain, may directly
inhibit neurons in arousal systems such as the LC, TMN, and
orexin neurons via the A1 receptor (Liu and Gao, 2007; Oishi
et al., 2008; Pan et al., 1995; Strecker et al., 2000). On the other1032 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.hand, A2a receptors are highly enriched in the striatum and in the
meningeal cells underlying the VLPO (Svenningsson et al., 1997).
We focus here on the A2a receptors near the VLPO, although it is
possible that A2a receptors in the striatum, or at other sites not
yet known to play a role in sleep state switching, may also be
involved (Qiu et al., 2010). Application of an A2a agonist to the
subarachnoid space underlying the VLPO causes sleep and
induces Fos in the VLPO and the underlying meninges (Scam-
mell et al., 2001). In addition, the wake-promoting drug caffeine
is believed to act through blockade of A2a receptors as caffeine
loses its wake-promoting effect in A2a receptor knockout mice
(Huang et al., 2005). Given the absence of A2a mRNA in the
VLPO, these findings suggest that adenosine may cause the
meningeal cells to produce a second messenger that activates
the VLPO. Whole-cell patch-clamp studies of the effects of
adenosine on VLPO neurons in hypothalamic slices have
produced conflicting results. Two studies using patch-clamp
intracellular recordings reported that adenosine disinhibited
VLPO neurons by reducing presynaptic inhibitory inputs
(Chamberlin et al., 2003; Morairty et al., 2004; Strecker et al.,
2000), but another study using extracellular recordings found
that adenosine reduced firing of VLPO neurons via a direct A1
effect but increased it via an A2a effect (Gallopin et al., 2005).
It is not known whether these hypothalamic slices may have
retained the basal meninges, but future work should probably
make note of this. These effects of adenosine on VLPO neurons
may bias the switch toward increased activity and thus increase
the likelihood of it flipping into a sleep state. Models of the
flip-flop switch under conditions of high sleep pressure on the
VLPO indicate that it may become more unstable (Fulcher
et al., 2010), perhaps accounting for microsleep episodes and
lapses in attention seen in human subjects during sleep depriva-
tion (Van Dongen et al., 2003). Still, it is unlikely that adenosine
alone can explain the homeostatic drive for sleep and much
ongoing work focuses on additional sleep-promoting factors
(Krueger, 2008).
Regardless of what constitutes the homeostatic sleep factors,
there is much evidence that prolonged wakefulness results in
more intense slow waves in the EEG during NREM sleep and
that these decrease over the sleep period (Achermann and Bor-
be´ly, 2003). This relationship suggests that the slowwave activity
is homeostatically controlled and reflects sleep drive (Vyazovskiy
et al., 2009). Slow waves during NREM sleep represent
the summation of synaptic potentials onto cortical neurons,
which are hyperpolarized and silent (in a down state) during
the troughs of the waves and fire bursts of action potentials
(in an up state) during the peaks. The duration and frequency
of the down periods correlates strongly with the intensity of
slowwave activity during spontaneous sleep and recovery sleep.
Prolonged wakefulness increases the firing rates of cortical
neurons (Vyazovskiy et al., 2009), and cortical areas that recently
have been especially active have local increases in slow waves
during subsequent NREM sleep, suggesting that the slow
wave activity may be homeostatically driven (Huber et al.,
2004; Vyazovskiy et al., 2000). It has been proposed that the
slow wave activity may reflect synaptic reorganization during
sleep in response to recent activity (Vyazovskiy et al., 2009),
but it is also possible that the increased metabolic activity may
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that drive slow wave activity (Bjorness et al., 2009; Halassa
et al., 2009).
Recordings from VLPO neurons across the wake-sleep cycle
show that their firing rates increase with EEG slow waves
(Szymusiak et al., 1998). During recovery sleep after 12 hr of
sleep deprivation, the slow wave power in the EEG and the firing
of VLPO neurons both approximately double. On the other hand,
the firing of VLPO neurons does not increase during prolonged
wakefulness. Thus, as homeostatic sleep drive accumulates,
it may influence other neurons in the brain, such as the median
preoptic neurons, which provide input to the VLPO (Chou
et al., 2002; Gvilia et al., 2006), but VLPO neurons do not fire until
the state transition itself (Takahashi et al., 2009). This funda-
mental property of VLPO neurons is consistent with their role in
causing rapid and complete state transitions.
A second major influence on sleep state switching is the input
from the circadian system (Achermann and Borbe´ly, 2003;
Borbe´ly and Tobler, 1985). In mammals, daily rhythms are driven
by the suprachiasmatic nucleus (SCN) in the hypothalamus,
a key pacemaker that influences the timing of a wide range of
behaviors and physiological events. SCN neurons are intrinsi-
cally rhythmic and drive behavioral responses with a roughly
24 hr period, even in complete darkness. This rhythmicity is
generated by a network of transcriptional/translational/post-
translational feedback loops that regulate the expression of
clock genes (Jin et al., 1999; Reppert and Weaver, 2002). The
clock genes are themselves transcription factors that regulate
the expression of hundreds if not thousands of other genes.
The activity of the SCN is entrained to the daily light-dark cycle
by inputs from intrinsically photosensitive retinal ganglion cells
that express the photopigment melanopsin (Gooley et al.,
2001; Hattar et al., 2002). Lesions of the SCN, or disruption of
expression of key clock genes, results in loss of most circadian
rhythms (Bunger et al., 2000; Edgar et al., 1993; Moore and
Eichler, 1972).
Surprisingly, the SCN has very little direct output to either the
wake or sleep regulatory systems (Watts et al., 1987). Instead,
the bulk of its projections run into the subparaventricular zone,
a region just dorsal and caudal to the SCN. Cell-body-specific
lesions of the ventral subparaventricular zone nearly eliminate
the circadian rhythms of sleep and wakefulness, suggesting
that neurons in this region are necessary for conveying these
output signals (Lu et al., 2001). However, the ventral subparaven-
tricular neurons have few direct outputs to either wake or sleep
networks. Instead, they send axons to the dorsomedial nucleus
of the hypothalamus (Chou et al., 2003; Deurveilher and Semba,
2005). The dorsomedial nucleus contains GABAergic neurons
that heavily innervate the VLPO and glutamatergic neurons that
innervate the lateral hypothalamic area, including the orexin
neurons (Chou et al., 2003; Thompson et al., 1996). Cell-body-
specific lesions of the dorsomedial nucleus nearly eliminate the
circadian rhythms of sleep and wakefulness, as well as feeding,
locomotor activity, and corticosteroid secretion (although some
rhythms, such as body temperature and melatonin secretion
persist because they take a different pathway) (Chou et al.,
2003; Saper et al., 2005). This three-stage pathway from the
SCN to the subparaventricular zone and then to the dorsomedialnucleus appears necessary for conveying circadian information
to the neurons that control wake-sleep state switching, yet it still
allows some flexibility for altering the timing of sleep and wake-
fulness depending upon seasonal changes and the timing of
food availability (Fuller et al., 2008; Gooley et al., 2006; Mieda
et al., 2006).
In the absence of the dorsomedial nucleus, wake-sleep cycles
become ultradian, with 7–8 sleep-wake cycles per day. In mice
that are arrhythmic due to clock gene deletions, activity patterns
likewise become ultradian (Bunger et al., 2000). However, there
is a paucity of information concerning whether the wake-sleep
cycles of individual animals become ultradian as well because
the few reports on sleep behavior in such mice provide only
graphs that summate across groups of animals, which obscures
whether ultradian cycles (which are not synchronized across
animals) were present (Laposky et al., 2005; Wisor et al., 2002).
Like lesions of the SCN in primates, lesions of the dorsomedial
nucleus in rats, or deletions of certain clock genes (such as
cryptochromes 1 and 2 or Bmal1), which cause loss of circadian
cycling of the SCN in mice, reduce the total amount of wakeful-
ness (Chou et al., 2003; Edgar et al., 1993; Laposky et al., 2005;
Wisor et al., 2002). These observations suggest that the
circadian systemmainly promotes wakefulness during the active
period, which is consistent with the main outputs of the dorso-
medial nucleus being to inhibit the VLPO and excite lateral
hypothalamic neurons.
Finally, animals often encounter conditions in their environ-
ment that require urgent alterations of specific physiological
responses, including wake-sleep states. These would include
stressful situations, such as confronting a predator or a hostile
conspecific but also situations such as encountering a potential
mate, seasonal changes, or the need for migration that may
require an adjustment of wake-sleep behavior (Palchykova
et al., 2003; Rattenborg et al., 2004). These situations have been
called allostatic loads by McEwen and colleagues (McEwen,
2000), and they require additional circuitry for modifying wake-
sleep cycles.
One common stressor in the wild is a lack of food, and in small
animals that can carry minimal energy reserves, the effects of
food deprivation on sleep are dramatic. Food-deprived mice
have marked increases in wakefulness and locomotor activity,
probably reflecting a strong drive to forage for food. However,
mice lacking the orexin-producing neurons show very little
arousal or increase in locomotion when food deprived, suggest-
ing that these cells are required for the arousing effects of hunger
(Yamanaka et al., 2003). In contrast, mice lackingMCH show just
the opposite response to food deprivation, with exaggerated
increases in locomotion, more wakefulness, and much less
REM sleep than normal mice (Willie et al., 2008). Most likely,
both the orexin and MCH neurons respond to the stress of
insufficient food but with quite opposite effects on sleep-wake
pathways.
Another common allostatic load is behavioral stress, which
frequently causes insomnia. For example, mice exposed
to foot shock or restraint stress have increased activity of corti-
cotrophin-releasing hormone (CRF) neurons that may cause
arousal by exciting the orexin neurons through CRF-R1 recep-
tors (Winsky-Sommerer et al., 2005). In another study, CanoNeuron 68, December 22, 2010 ª2010 Elsevier Inc. 1033
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insomnia by placing a male rat early in the sleep period into
a cage previously occupied by another male rat. The stressed
rat took twice as long to fall asleep as control animals placed
into a clean cage and then had disturbed sleep for the remainder
of the next 6 hr, sleeping only about 50% (instead of the usual
70%–80%) of the fifth and sixth hours after cage exchange. At
the end of this period, the insomniac animals expressed Fos in
a surprising pattern: both the VLPO and some of the arousal
systems (LC and TMN) were active. This dual activation of both
the wake and sleep circuitry suggests that the VLPO was
activated by both homeostatic and circadian sleep drives, while
the LC and TMNwere driven by the allostatic stress. Thus stress-
induced insomnia may represent an unusual state in which
neither side of the wake- and sleep-regulating circuitry is able
to overcome the other because both receive strong excitatory
stimuli.
These stressed animals also expressed Fos in the infralimbic
cortex, the central nucleus of the amygdala, and the bed nucleus
of the stria terminalis (Cano et al., 2008). These corticolimbic
sites project to the LC and TMN, as well as the areas in the upper
pons that regulate REM sleep switching (Dong et al., 2001;
Hurley et al., 1991; Van Bockstaele et al., 1999). The infralimbic
cortex also provides a major input to the VLPO (Chou et al.,
2002).These inputs may be important in maintaining a waking
state during periods of high behavioral arousal, such as an
emergency that occurs during the normal sleep period. Their
activation by residual stress or anxiety may contribute to inability
to sleep in stress-induced insomnia. Lesions of the infralimbic
cortex reduce Fos expression in the LC and the TMN and restore
NREM but not REM sleep in animals with experimental stress-
induced insomnia (Cano et al., 2008). Lesions of the extended
amygdala, including the bed nucleus of the stria terminalis,
also quieted both arousal systems, as well as the infralimbic
cortex, and restored both REM and NREM sleep. Thus, it
appears that the activation of medial prefrontal and amygdaloid
circuitry can drive arousal circuitry even in the face of VLPO
activity (a state that has been called hyperarousal). These
stressed rats also had excessive high-frequency EEG activity
during NREM sleep, consistent with cortical activation, even
during periods of slow wave generation. Increased activation
of these corticolimbic sites has also been demonstrated in
human subjects with insomnia (Nofzinger et al., 2004). This coac-
tivation may also contribute to the excessive high-frequency
EEG activity seen during NREM sleep in people with insomnia,
and the sensation in some insomniacs that they are awake
even when the EEG appears to be NREM sleep, a condition
known as ‘‘sleep state misperception.’’
One common feature of stressful situations is the need to
maintain vigilance. The medial prefrontal cortex, in addition to
providing the major cortical source of inputs to the wake-sleep
system, plays a critical role in determining which stimuli in the
environment require attention (Aston-Jones and Cohen, 2005).
It therefore may provide an important wake-promoting input
when attention to the environment is required. In humans who
have been sleep deprived, there is decreased activation of the
medial prefrontal cortex during tasks that require sustained
attention (Chee and Choo, 2004; Chuah et al., 2006). Thus,1034 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.excessive homeostatic drive for sleep may ultimately degrade
the ability of the allostatic system to maintain wakefulness.
Switches Gone Bad: The Example of Narcolepsy
The common sleep disorder narcolepsy is an excellent clinical
example of how sleep switches can become destabilized by
loss of a single component of the sleep-wake circuitry. Narco-
lepsy was first described over 125 years ago (Gelineau, 1880;
Westphal, 1877), but only in the last 10 years has the underlying
neurobiology become clear. People with narcolepsy often have
severe sleepiness that makes it a struggle to stay awake at
school or remain alert while driving. In addition, these individuals
frequently have what appear to be fragments of REM sleep that
intrude into wakefulness: vivid, often frightening, dream-like
hallucinations as they drift off to sleep and cataplexy, brief
episodes of muscle paralysis triggered by strong emotions.
These symptoms typically begin abruptly in the teens or young
adulthood and then persist for life. For years, researchers sus-
pected that narcolepsy was caused by some dysfunction of
the hypothalamus or REM sleep-regulating pathways, but the
fundamental neuropathology had remained a mystery until the
last few years.
Substantial research has now established that narcolepsy is
caused by a selective loss of orexin signaling in the brain. This
connection was first made in 1999, when Lin and colleagues
(Lin et al., 1999) found that dogs with inherited narcolepsy had
an exon-skipping mutation in the type 2 orexin receptor gene.
At the same time, Chemelli and colleagues (Chemelli et al.,
1999) reported that mice with a deletion of the gene coding for
the orexin peptides displayed severe sleepiness and cataplexy-
like events. The following year, two groups of investigators found
that patients who had narcolepsy with cataplexy had a 90% or
greater loss of the orexin-producing neurons (Peyron et al.,
2000; Thannickal et al., 2000). This finding was quite selective,
as theMCHneurons, which are intermingledwith the orexin cells,
were completely spared, and it probably represented cell loss
rather than downregulation of orexin expression as there was
concomitant loss of other markers (dynorphin and neuronal
activity-related pentraxin) of the orexin cell population (Crocker
et al., 2005). The loss of orexins is not due to a simple genetic
abnormality, as orexin deficiency is acquired during young
adulthood, and the vast majority of people with narcolepsy do
not have mutations of the genes encoding the orexin peptides
or their OX1 or OX2 receptors (Olafsdo´ttir et al., 2001; Peyron
et al., 2000). However, because about 90%of people with narco-
lepsy have human leukocyte antigen DQB1*0602 (Mignot et al.,
2001), researchers have hypothesized that the loss of orexin
neurons may be immune-mediated (Lim and Scammell, 2010;
Scammell, 2006). It has recently been proposed that, at least in
some individuals, an autoimmune attack on the orexin neurons
may be related to antibodies to Tribbles homolog-2, a protein
produced by the orexin neurons and other cells in the brain (Cvet-
kovic-Lopes et al., 2010; Kawashima et al., 2010).
Several models have been proposed to explain how loss of the
orexin neurons results in severe sleepiness. One popular hypoth-
esis is that individuals with narcolepsy may be more sensitive to
homeostatic sleep drive as, after a period of sleep deprivation,
they fall asleep faster than normal (Tafti et al., 1992a, 1992b).
Figure 5. Summary of the Cascading Wake-Sleep and
REM-NREM Flip-Flop Switches and How They Are
Both Stabilized by Orexin Neurons
The populations of wake- and sleep-promoting neurons are
shown as components of a counterpoised switch at the upper
left and the REM-on and REM-off populations at the lower
right. (Red arrows indicate inhibitory projections and green
arrows excitatory ones.) The monoaminergic arousal neurons
that inhibit the VLPO during wakefulness also inhibit the REM-
on and excite the REM-off neurons in the REM switch, thus
making it nearly impossible for normal individuals to transition
directly from wakefulness to a REM state. On the other hand,
when there is loss of orexin signaling in narcolepsy, both
switches become destabilized and their normal cascading
relationship is disrupted so that it is possible for individuals
with narcolepsy to enter fragmentary components of REM
sleep (cataplexy, sleep paralysis, and hypnagogic hallucina-
tions) directly from the waking state. The clinical phenomena
encountered in narcolepsy when each population of wake-,
sleep-, or REM-promoting neurons fires at the wrong time is
identified in parentheses. Modified from Lu et al., 2006b.
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being deprived of sleep, but they recover the lost sleep at
a normal rate and to the same extent as wild-type mice (Mochi-
zuki et al., 2004). Thus, orexin deficiency hastens the transition to
sleep, but the accumulation and expression of homeostatic
sleep drive appears normal in mice and people with narcolepsy
(Khatami et al., 2008; Mochizuki et al., 2004). Another potential
explanation is that circadian waking drive is impaired in narco-
lepsy. However, this too seems unlikely as mice lacking orexins
have normal circadian rhythms of wake and NREM sleep when
housed in constant darkness (Kantor et al., 2009; Mochizuki
et al., 2004).
A better explanation may be that impaired orexin signaling
causes behavioral states to become unstable (Figure 5). In
fact, this idea was first raised by Broughton over 20 years ago
as narcoleptic people and animals have great difficulty remaining
awake, but they also have fragmented sleep and many more
transitions between all states (Broughton et al., 1986).
This breakdown in the ability to produce cohesive wake and
sleep states is consistent with a destabilized switching mecha-
nism. Across 24 hr, people and animals with narcolepsy have
essentially normal amounts of wake and sleep, but they have
manymore transitions between states. Under normal conditions,
the sleep-wake switch resists switching until a sufficiently
strong stimulus such as homeostatic sleep drive accumulates
to a critical level. In contrast, most individuals with narcolepsy
can rapidly doze off at any time of day, especially when they
are sedentary. Narcoleptic mice also transition quickly and
frequently from well-established wake into NREM sleep (Diniz
Behn et al., 2010; Kantor et al., 2009; Mochizuki et al., 2004).
At the same time, because orexins activate REM sleep-
suppressing neurons, loss of the orexin neurons permits moreNeurfrequent transitions into REM sleep. Patients may
enter REM sleep after only brief periods of NREM
sleep, and REM sleep can occur at any time of
day (Dantz et al., 1994; Rechtschaffen et al.,
1963). In addition, people and animals with narco-
lepsy often enter into partial REM sleep-like states,such as cataplexy, in which strong, generally positive emotions
activate the REM sleep atonia pathways in the midst of wakeful-
ness. At other times, the atonia of REM sleep can persist for
a minute or two upon awakening (sleep paralysis) or vivid,
dream-like hypnagogic hallucinations can occur around the
onset of sleep. These phenomena rarely occur in healthy, well-
rested individuals because the orexin neurons reinforce the
activity of themonoaminergic neurons in the LC and dorsal raphe
nucleus (Bourgin et al., 2000; Kohlmeier et al., 2008), which in
turn activate REM-off neurons and inhibit REM-on neurons,
thus locking the individual out of REM sleep and its component
behaviors during wakefulness. We propose that these frequent
transitions between states, odd mixtures of states, and poor
control of REM sleep are consistent with destabilization of the
flip-flop switches that regulate REM-NREM and wake-sleep
transitions because of the loss of orexin signaling.
Several lines of research are now beginning to identify how
orexin deficiency destabilizes the wake-sleep switch. In normal
animals, the orexin neurons are active during wakefulness, espe-
cially during active exploration of the environment (Estabrooke
et al., 2001; Lee et al., 2005; Mileykovskiy et al., 2005), and
they provide excitatory tone to wake-promoting monoaminergic
and cholinergic cell groups. In the absence of this activity, these
key arousal systems may have reduced or inconsistent activity,
which would manifest as sleepiness and frequent transitions
into sleep. Orexins have no direct effects on VLPO neurons,
but may increase presynaptic inhibition of VLPO neurons (Egger-
mann et al., 2001; Methippara et al., 2000). Both of these mech-
anisms are supported by mathematical modeling (Diniz Behn
et al., 2008; Rempe et al., 2010). Thus, reduced activity in
wake-promoting neurons and less inhibition of the VLPO could
destabilize the sleep-wake switch.on 68, December 22, 2010 ª2010 Elsevier Inc. 1035
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sleep atonia pathways during wakefulness, but how these
events are triggered by strong positive emotions, such as
laughter and joking, remains a mystery. Feeling weak with
laughter is common inmany cultures, and even in normal individ-
uals laughter briefly reduces muscle tone (Overeem et al., 1999).
However, in people with narcolepsy, positive emotions can
trigger partial or generalized atonia. In fact, as cataplexy
develops, people often have intermittent lapses in tone that
then develop into sustained paralysis lasting a minute or two.
This intermittent atonia strongly suggests instability in the brain-
stem switch controlling atonia. As suggested by Nishino et al.
(2000), it seems likely that cataplexy is caused by ‘‘increased
sensitivity in the pathways that link emotional input and spinal
motor inhibition’’. The flip-flop switch model predicts that in
normal individuals, even though laughter may inhibit the motor
tone-producing system, orexins may prevent transitions into
full atonia. In the absence of orexins, these emotionally triggered
signalsmay be unopposed, permitting full activation of the atonia
pathways.
In this model, orexins may act through several pathways to
inhibit cataplexy. First, during cataplexy, LC and dorsal raphe
neurons are essentially silent, just as in REM sleep (Wu et al.,
1999, 2004). However, the histaminergic neurons of the TMN
remain active, possibly accounting for the preservation of
consciousness during this state (John et al., 2004).Orexins excite
neurons of the LC and dorsal raphe nucleus(Brown et al., 2001;
Hagan et al., 1999), and drugs that increase noradrenergic or
serotoninergic tone suppress cataplexy (Nishino and Mignot,
1997). Thus, enhancement of monoaminergic tone by orexins
may directly increase the activity of motor neurons and inhibit
brainstem atonia mechanisms. In addition, orexins may directly
and indirectly excite bulbar and spinal motor neurons probably
via OX2 receptors (Fung et al., 2001; Greco and Shiromani,
2001; Peever et al., 2003; Volgin et al., 2002; Yamuy et al., 2004).
Looking Forward to Sleep
We have reviewed some of the current thinking on the regula-
tion of sleep and wakefulness and how this might be influenced
by mutually inhibitory circuitry functioning analogous to elec-
tronic flip-flop switches. We recognize that this is a working
model that has stimulated active debate and that there are
alternative models of sleep state switching (e.g., the Hobson-
McCarley model of REM state switching, as discussed above).
However, we expect that ongoing and future experimental tests
of the model will help resolve the many important questions
that remain to be addressed. For example, both wake and
sleep may be governed by additional brain regions not yet iden-
tified, as lesions of the cholinergic or monoaminergic neurons
in the brainstem, hypothalamus, or basal forebrain have only
minimal effects on the total amounts of sleep or wakefulness.
Even lesions of several of these cell groups in combination
have only slightly greater effects (Blanco-Centurion et al.,
2007). Similarly, even very large and complete lesions of the
VLPO at most reduce sleep by about 50%, suggesting that
there are other pathways capable of inhibiting the ascending
arousal system in the absence of VLPO neurons. Thus, there
are likely to be components of our proposed wake-sleep flip-1036 Neuron 68, December 22, 2010 ª2010 Elsevier Inc.flop switch that are as yet unknown, and evidence in support
of this switch and its full understanding will require a more
complete knowledge of its components. In addition, it will be
important to gain a more complete understanding of the inter-
actions of these components of both the proposed wake-sleep
and NREM-REM sleep switches, and to test these circuit
models rigorously. One challenge in dissecting these circuits
and testing their functions is that wake-promoting and sleep-
promoting cell populations may overlap spatially in some
locations. Fortunately, these neurons have different neurotrans-
mitters and connections, which allow us to introduce novel
genetic and transneuronal methods for manipulating them
independently. Approaches might include testing the functional
roles of these components with optogenetic or perhaps
genetically driven, ligand-gated channels such as ivermectin-
activated chloride channels (Adamantidis et al., 2007; Lynagh
and Lynch, 2010). It would be particularly valuable to record
simultaneously from neurons in multiple components of a
putative switch while driving one component and to examine
their firing patterns across wake-sleep or NREM-REM sleep
transitions.
We also know little about the mechanisms by which homeo-
static sleep drive is either accumulated or discharged. Current
evidence points to a role of adenosine, but it is unlikely that
this explains the entire process as adenosine levels in many
parts of the brain do not increase with prolonged wakefulness
(Strecker et al., 2000) and homeostatic sleep drive persists
even in the absence of adenosine receptors. It remains possible
that slower, progressive changes as animals rest before sleep
may contribute to modulating the flip-flop switch and are not
necessarily in conflict with this model. Multiple neuronal
dynamics with different time scales are likely to occur within
the wake-sleep system. Such slower modulation may contribute
to reducing noise and stabilizing the switch and could help
explain how putative flip-flop switches could accommodate
noisy, unstable neuronal circuits and integrate multiple influ-
ences into sharp transitions. It will also be important to under-
stand better how motivation and emotions influence the wake-
sleep system. As these terms imply, these drivers for animal
behavior involve movement, which is the antithesis of quiet
sleep. Unraveling how the orexin neurons and other systems
impelmotivated behaviors, addictions, and rewardwill be impor-
tant new vistas for understanding their overall role in the func-
tions of the brain. At the same time, we need to understand
how stress, anxiety, and depression can drive insomnia. Finally,
the extent to which the wake-sleep circuitry is so deeply
embedded within the brain and intricately related to circuitry
controlling movement, motivation, and emotion suggests that
sleep is fundamentally important for normal brain function. Yet
the way in which sleep is restorative and why brain function is
impaired in its absence remain among the most enduring
mysteries of neuroscience.
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